Edwards Lifesciences Corporation (EW) New York Stock Exchange
155.02-5.11-3.19%
CloseDecember 17, 2018

News: updated – 18-Dec 09:38


Credit Suisse sees 18% upside in Abbott in premarket analyst action18-Dec 08:05(SeekingAlpha)

Abbott (NYSE: ABT ) initiated with Outperform rating and $82 (18% upside) price target at Credit Suisse. More news on: Abbott Laboratories, Alnylam Pharmaceuticals, Inc., Baxter International Inc, Healthcare stocks news, Stocks on the move, , Read more …

AtriCure Is An Interesting Buy In December 201814-Dec 05:03(SeekingAlpha)

Having the only PMA product for the surgical treatment of atrial fibrillation (or Afib), AtriCure ( ATRC ) is today looking at a highly underserved market opportunity. It is estimated that 17 million patients across the world and 6 million in the U.S. suffer from Afib, of which, a wide major…

The S&P 500 And You: Why Most Investors Did Not Beat The Market In 201814-Dec 01:24(SeekingAlpha)

Underperformed your benchmarks this year? There are quite a few reasons why that likely occurred most of which are reoccurring. As we get into the close of what has been a very tough Q4, I wanted to disseminate the data I generally put together each December on S&P 500 ( SPY ) c…